Transfer

News

All

Transfer

Public Engagement

Awards & Grants

Diabetes

Stem Cells

Environmental Health

Computational Health

Bioengeineering

Molecular Targets & Therapeutics

Pioneer Campus

Nurse and patient in hospital bed with medical monitors

Transfer, Diabetes, HI-MAG,

Translation: Where Medical Research Reaches People

How can we bring new scientific insights to patients more quickly? At Helmholtz Munich, we work hand in hand with leading clinics across Germany to translate research findings directly and purposefully into new therapeutic approaches — and,…

Helmholtz Biomedical Engineering Initiative

AI, Transfer, Bioengineering, IBMI, Pioneer Campus,

Helmholtz Biomedical Engineering Initiative: Shaping the Future of Health

The Helmholtz Association is launching a nationwide biomedical engineering initiative to accelerate technology development and transfer activities. Led by its established Health Centers, “Helmholtz Biomedical Engineering” brings together cutting-edge…

A dynamic web of entities and people working together to foster and advance new ideas, technologies, and solutions.

Transfer, Bioengineering, IBMI, Pioneer Campus,

From Lab Bench to Startup: New Doctorate Program Offers Scientists a Venture-Building Path

Helmholtz Munich is partnering with Deep Science Ventures (DSV) and SPRIND, Germany’s Federal Agency for Disruptive Innovation, to support the Venture Science Doctorate (VSD) – a novel doctoral program designed to train scientists to build…

Close-up of a vial labeled Hepatitis B with a blood sample.

Transfer, Molecular Targets and Therapeutics, VIRO,

Therapeutic Vaccine for Chronic Hepatitis B Enters First Clinical Trial in Patients

TherVacB, a novel therapeutic vaccine for chronic hepatitis B developed under the leadership of Helmholtz Munich, has entered its first clinical trial in patients. Following a successful phase 1a trial in healthy volunteers, where the vaccine…

Start of the M1 Munich Medicine Alliance

Transfer,

Start of the M1 Munich Medicine Alliance

The M1 Munich Medicine Alliance has officially launched, bringing together the two Munich-based Excellence Universities – Ludwig-Maximilians-Universtiät (LMU) and the Technical University of Munich (TUM) – along with their associated university…

Gene-editing scissors cut a DNA strand

Transfer,

License Agreement to Expand its CRISPR/Cas9 Gene Editing Services

Taconic Biosciences, a global leader in providing animal model solutions and services, entered into an exclusive license agreement with Helmholtz Munich to provide preclinical researchers with advanced CRISPR gene editing services. Through this…